Metabolic Complications of Androgen Deprivation Therapy for the Treatment of Prostate Cancer

  • Helen Anaedo
  • Published 2015


Aim: Prostate cancer is the most commonly diagnosed cancer and second leading cause of cancer death in U.S. men. The b median age at diagnosis is 67 years, with black men having a 50% higher risk of developing prostate cancer and two-fold mortality rate compared with Caucasians. The use of androgen deprivation therapy (ADT) is associated with symptom… (More)